Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice
- PMID: 7505315
- DOI: 10.1046/j.1471-4159.1994.62010380.x
Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice
Abstract
Administration of methamphetamine (METH) to rats and nonhuman primates causes loss of terminals in the nigrostriatal dopaminergic system. The mechanism by which METH causes its neurotoxicity is not known. To evaluate further the role of oxyradicals in METH-induced neurotoxicity, we have tested its effects in CuZn superoxide dismutase (SOD) transgenic (Tg) mice, which express the human CuZnSOD gene. In non-Tg mice, acute METH administration causes significant decreases in levels of dopamine (DA) and 3,4-dihydroxyphenylacetic acid (DOPAC) in the striata and cortices of non-Tg mice. In contrast, there were no significant decreases in cortical or striatal DA in the SOD-Tg mice. The effects of METH on DOPAC were also attenuated in both structures of these SOD-Tg mice. Chronic METH administration caused decreases in levels of striatal DA and DOPAC in the non-Tg mice, whereas the SOD-Tg mice were not affected. These results suggest that METH-induced dopaminergic toxicity in mice may be secondary to increased production of reactive oxygen species such as the superoxide radical.
Similar articles
-
Neurotoxicity, drugs and abuse, and the CuZn-superoxide dismutase transgenic mice.Mol Neurobiol. 1995 Aug-Dec;11(1-3):155-63. doi: 10.1007/BF02740692. Mol Neurobiol. 1995. PMID: 8561959 Review.
-
Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice.Brain Res. 1996 Apr 1;714(1-2):95-103. doi: 10.1016/0006-8993(95)01502-7. Brain Res. 1996. PMID: 8861613
-
Involvement of oxygen-based radicals in methamphetamine-induced neurotoxicity: evidence from the use of CuZnSOD transgenic mice.Ann N Y Acad Sci. 1994 Nov 17;738:388-91. doi: 10.1111/j.1749-6632.1994.tb21827.x. Ann N Y Acad Sci. 1994. PMID: 7530424 No abstract available.
-
Methamphetamine-induced changes in antioxidant enzymes and lipid peroxidation in copper/zinc-superoxide dismutase transgenic mice.Ann N Y Acad Sci. 1998 May 30;844:92-102. Ann N Y Acad Sci. 1998. PMID: 9668667
-
Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts.Ann N Y Acad Sci. 2001 Jun;939:366-80. doi: 10.1111/j.1749-6632.2001.tb03646.x. Ann N Y Acad Sci. 2001. PMID: 11462792 Review.
Cited by
-
Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum.J Neurosci. 2005 Jun 1;25(22):5273-9. doi: 10.1523/JNEUROSCI.4893-04.2005. J Neurosci. 2005. PMID: 15930374 Free PMC article.
-
Bcl-2 sensitivity differentiates two pathways for motoneuronal death in the wobbler mutant mouse.J Neurosci. 1996 Oct 1;16(19):5897-904. doi: 10.1523/JNEUROSCI.16-19-05897.1996. J Neurosci. 1996. PMID: 8815872 Free PMC article.
-
The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders.Front Microbiol. 2015 Oct 23;6:1164. doi: 10.3389/fmicb.2015.01164. eCollection 2015. Front Microbiol. 2015. PMID: 26557111 Free PMC article. Review.
-
Modulation of methamphetamine-induced nitric oxide production by neuropeptide Y in the murine striatum.Brain Res. 2012 Nov 5;1483:31-8. doi: 10.1016/j.brainres.2012.09.013. Epub 2012 Sep 13. Brain Res. 2012. PMID: 22982589 Free PMC article.
-
Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis.J Neurosci. 2002 Oct 15;22(20):8951-60. doi: 10.1523/JNEUROSCI.22-20-08951.2002. J Neurosci. 2002. PMID: 12388602 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous